Skip to main content
. Author manuscript; available in PMC: 2011 Jul 9.
Published in final edited form as: Genet Med. 2009 Oct;11(10):750–756. doi: 10.1097/GIM.0b013e3181b3a697

Table 1.

Criteria for adherence to guidelines

ACMG 2001 CAP 2002 GHC 2002
First episode of VTE Age younger than 50 yr Age younger than 50 yr Age younger than 50 yr and idiopathic
Any age if family history of VTE Any age, unprovoked Age younger than 50 yr and strong family history of DVT
If pregnant or taking o.c. Any age, if family history of VTE at age younger than 50 yr If pregnant
Age older than 50 yr if no malignancy If pregnant, postpartum, taking o.c. or HRT
Recurrent VTE Yes Yes Same criteria as first episode of VTE
VTE at unusual site Yes Yes Same criteria as first episode of VTE
Pregnancy outcome (other than fetal loss) Unexplained severe pre-eclampsia, IUGR, or placental abruption No NA
Fetal loss If recurrent or stillbirth If unexplained and in second or third trimester NA
Arterial thrombosis (including stroke) No (except if age younger than 50 yr and no other risk factors) No (except if unexplained and no risk factors or in young smokers) NA
Myocardial infarction Females if age younger than 50 yr No NA
Family history of FVL Yes Yes Only if first-degree relatives
Family history of VTE If VTE at age younger than 50 yr No No

o.c., oral contraceptives; HRT, hormone replacement therapy; IUGR, intrauterine growth retardation; NA, indicates that this testing indication was not covered in the text of the guidelines; No, indicates that the guidelines do not recommend testing for this indication.